• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Adult-onset Still's Disease

Adult-onset Still's Disease - 5 Studies Found

Completed : Canakinumab for Treatment of Adult Onset Still's Disease
: Adult-Onset Still´s Disease
: 2014-07-29
:
  • Drug: Canakinumab Canakinumab

Completed : Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
: Adult-Onset Still's Disease
: 2009-12-15
:
  • Drug: anakinra 100 mg subcutan

Completed : Efficacy and Safety of Tocilizumab in Adult's Still Disease
: Adult's Still Disease
: 2009-10-26
: Drug: Tocilizumab Tocilizumab, IV, 8 mg/kg, every 2 weeks
Completed : Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
: Still's Disease, Adult-Onset
: 2015-02-23
: Biological: Tadekinig alfa (recombinant human IL-18 binding protein) Patients received the study treatme
Completed : Interleukin-1 Trap to Treat Autoinflammatory Diseases
:
  • Inflammation
  • Familial Mediterranean Fever
  • Still's Disease,
    : 2004-10-28
    : Drug: IL-1 Trap
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.